Raymond James Financial Services Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,786
Closed -$574K 2957
2019
Q2
$574K Sell
5,786
-9,789
-63% -$934K ﹤0.01% 1835
2019
Q1
$1.72M Buy
+15,575
New +$1.63M 0.01% 1156
2018
Q4
Sell
-6,049
Closed -$667K 2910
2018
Q3
$667K Buy
+6,049
New +$630K ﹤0.01% 1717
2018
Q1
Sell
-12,317
Closed -$1.12M 2780
2017
Q4
$1.12M Buy
+12,317
New +$1.02M 0.01% 1230

Other funds holding PRAH

Raymond James Financial Services Advisors's PRAH Position: Q3 2019 in Review

Raymond James Financial Services Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 5,786 shares — an estimated $574K sold.

Raymond James Financial Services Advisors first reported a position in PRAH in Q4 2017 and held it in 4 quarters. The position peaked at $1.72M in Q1 2019. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

  • Raymond James Financial Services Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 5,786 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $574K.
  • Raymond James Financial Services Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 4 quarters.
  • Raymond James Financial Services Advisors's PRA Health Sciences, Inc. position peaked at $1.72M in Q1 2019.
  • 329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2019, filed 7 Nov 2019.